DERMATOLOGY PRACTICE DURING COVID-19 PANDEMIC - CASE REPORTS |
|
Year : 2021 | Volume
: 5
| Issue : 1 | Page : 30-33 |
|
Management of toxic epidermal necrolysis in an adult patient: Challenges and their management during COVID-19 pandemic
Ragunatha Shivanna1, Gaurav Ramakrishna2, Godwin K Mannur2
1 Department of Dermatology, Venereology and Leprosy, PGIMSR, Bengaluru, Karnataka, India 2 Department of ESIC Medical College and PGIMSR, Bengaluru, Karnataka, India
Correspondence Address:
Ragunatha Shivanna Professor and Head, Department of Dermatology, Venereology and Leprosy, ESIC Medical College and PGIMSR, Rajajinagar, Bengaluru - 560 010, Karnataka India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/cdr.cdr_125_20
|
|
An adult male patient who underwent neurosurgery for extradural hematoma following road traffic accident presented with toxic epidermal necrolysis (TEN) secondary to phenytoin. The patient was semiconscious and not responding to verbal commands. The patient was admitted and managed with oral cyclosporine and supportive measures. TEN is a dermatological emergency presenting as acute skin failure. The management requires multidisciplinary approach in an intensive care setup. The treatment includes the administration of immunosuppressant drugs and maintenance of hemodynamic stability. However, the COVID-19 pandemic has resulted in a lot of limitations regarding the use of immunosuppressant drugs and in-patient care because of the possibility of transmission of COVID-19 infection among patients, their caretakers and health-care professionals. Here, we are presenting a case of TEN managed successfully during the pandemic of COVID-19. Strict adherence to all the guidelines recommended by concerned authorities related to the prevention of transmission of COVID-19 and judicious use of immunosuppressant drugs based on risk and benefit ratio is very crucial.
|
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|